BridgeBio Pharma (BBIO) Tax Provisions (2024 - 2025)
BridgeBio Pharma's (BBIO) quarterly Tax Provisions came in at -$120000.0 in Q4 2025, down 110.41% year-on-year from $1.2 million in Q4 2024, and up 92.0% quarter-over-quarter from -$1.5 million in Q3 2025.
BridgeBio Pharma (BBIO) Tax Provisions (2024 - 2025) Analysis & Trends
BridgeBio Pharma has disclosed Tax Provisions across 2 years of filings, most recently posting -$120000.0 for Q4 2025.
- Tax Provisions for Q4 2025 came in at -$120000.0, down 110.41% year-over-year; the trailing twelve-month figure through Dec 2025 was $1.6 million (changed N/A YoY), and the FY2025 annual result was $435000.0, down 62.27% from the prior year.
- Tax Provisions came in at -$120000.0 for Q4 2025 at BridgeBio Pharma, up from -$1.5 million in the prior quarter.
- In the past five years, Tax Provisions ranged from a high of $2.1 million in Q2 2025 to a low of -$1.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -11.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 216,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -859,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 221.50 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | BridgeBio Pharma | 12.90 Bn | 11.97 Bn | 184.58 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -120,000.00 |
| Sep 30, 2025 | -1.50 Mn |
| Jun 30, 2025 | 2.10 Mn |
| Dec 31, 2024 | 1.15 Mn |